A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Vera BrilAndrzej SzczudlikAntanas VaitkusCsilla RozsaMaria JędrzejowskaPetr HonJosef BednarikMichaela TyblovaWolfgang KöhlerToomas ToomsooRichard J NowakTahseen MozaffarMiriam L FreimerMichael W NicolleTim MagnusMichael T PulleyMichael H RivnerMazen M DimachkieB Jane DistadRobert M PascuzziDonna BabiarJiang LinMontse Querolt CollRhonda GriffinElsa MondouPublished in: Neurology (2022)
This study provides Class II evidence that IVIG infusions in adult patients with MG do not increase the percentage of patients achieving a ≥ 50% reduction in corticosteroid dose compared to placebo.